1Hori T,Takahashi E, Ayusawa D, et al. Regional assignment of the human thymidylate synthase ( TS ) gene to chromosome band 18p11. 32 by nonisotopic in situ by hybridization. Hum Genet, 1990,85:576-580.
2Iacopetta B, Grieu F, Joseph D, et al. A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil. Br J Cancer,2001, 85:827-830.
3Kazuyuki K, awakami, K, Eiji K, et al. Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinalcancer. Anticancer Research, 1999, 19: 3249- 3252.
4Marsh S, Ameyaw MM, Githanga J, et al. Novel thymidylate synthase enhancer region alleles in African populations. Hum Mutat, 2002,16: 528.
5Kaneda S, Nalbantoglu J, Takeishi K. et al. Structural and functional analysis of the human thymidylate synthase gene. J Biol Chem, 1990,265: 20277 -20284.
6Marcuello E, Altes A, Del Rio E, et al. Single nucleotide polymorphism in the 5'tandem repeat sequences of thymidylate ynthase gene predicts for response to fluorouracil-based chemotherapy in dvaneed colorectal cancer patients, int J Cancer,2004,112:733-737.
7Kawakami K,Watanabe G. ldentigication and functional analysis of single nucleotide pulymorphism in the tandem repeat sequence of thymidylate synthase gene. Cancer Res,2003 ,63 :6004-6007.
8Ulrich CM, Bigler J, Velicer CM.et al. Searching expressed sequence tag databases synthase gene. Cancer Epidemiol Biomarkers Prey, 2000,9: 1381-5.
10Mandola MV, Stochlmacher J, Zhang W, et al. A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels. Pharmacogenetics, 2004,14:319-327.
二级参考文献5
1Marsh S, Collie-Duguid ESR, Li T, et al. Ethnic variation in the thymidylate synthase enhancer region polymorphism among caucasian and Asian population. Genomics, 1999,58 : 310-312.
2Horie N, Aiba H, Oguro K, et al. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct, 1995, 20:191-197.
3Ulrich CM, Bigler J. Velicer CM, et al. Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol Biomark Prev,2000,9 : 1381-1385.
4Chen J, Giovannucci E, Kelsey K, et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer.Cancer Res, 1996,56:4862-4864.
4Scagliotti GV,Selvaggi G.New data integrating multitargetedantifolates into treatment of first-line and relapsed non-small-cell lung cancer[J].Clin Lung Cancer,2008,9(Suppl 3):S122-S128.
5Scagliotti GV,Parikh P,von PJ,et al.PhaseⅢstudy compa-ring cisplatin plus gemcitabine with cisplatin plus pemetrexedin chemotherapy-naive patients with advanced-stage non-small-cell lung cancer[J].J Clin Oncol,2008,26(21):3543-3551.
6Rossi A,Ricciardi S,Maione P,et al.Pemetrexed in the treat-ment of advanced non-squamous lung cancer[J].Lung Cancer,2009,66(2):141-149.
7Rosell R,Felip E,Paz-Ares L.How could pharmacogenomicshelp improve patient survival[J].Lung Cancer,2007,57(Suppl2):S35-S41.
8Ulrich CM,Bigler J,Velicer CM,et al.Searching expressed se-quence tag databases:discovery and confirmation of a commonpolymorphism in the thymidylate synthase gene[J].CancerEpidemiol Biomarkers Prev,2000,9(12):1381-1385.
9Mandola MV,Stoehlmacher J,Zhang W,et al.A6 bp polymor-phism in the thymidylate synthase gene causes message insta-bility and is associated with decreased intratumoral TS mRNAlevels[J].Pharmacogenetics,2004,14(5):319-327.
10Dotor E,Cuatrecases M,Martinez-Iniesta M,et al.Tumor thy-midylate synthase 1494del6 genotype as a prognostic factor incolorectal cancer patients receiving fluorouracil-based adjuvanttreatment[J].J Clin Oncol,2006,24(10):1603-1611.
